Ignite Creation Date:
2024-05-05 @ 4:41 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00293059
Status:
COMPLETED
Last Update Posted:
2013-11-27
First Post:
2006-02-15
Brief Title:
Efficacy and Safety Study for the Treatment of Dysfunctional Uterine Bleeding
Sponsor:
Bayer
Organization:
Bayer
Study Overview
Official Title:
A Multicenter Double-Blind Randomized Parallel-Group Placebo- Controlled 7 Cycle Duration 196 Days Phase 3 Study of Oral Estradiol ValerateDienogest Tablets for the Treatment of Dysfunctional Uterine Bleeding
Status:
COMPLETED
Status Verified Date:
2013-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine whether the study drug is safe and effective in the treatment of dysfunctional uterine bleeding
Detailed Description:
This study has previously been posted by Berlex Inc Berlex Inc has been renamed to Bayer HealthCare Pharmaceuticals IncBayer HealthCare Pharmaceuticals Incis the sponsor of the trial
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 308960 | OTHER | Company internal | None |